GlassScriptPhysician profile
Gurston Nyquist
NPI 1699822536
$17,947.18
in general payments reported to CMS, 2019-2025
13 companies · $15K in 2025
The $15K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.87 · 2022: $302 · 2023: $392 · 2024: $1,845 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $1,471 · Travel and Lodging: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,681.99 |
| Food and Beverage | $1,470.69 |
| Travel and Lodging | $478.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $10,298.37 | 2022-2025 | |
| Regeneron Pharmaceuticals, INC. | $6,404.01 | 2025 | Dupixent |
| Medtronic, INC. | $531.34 | 2022-2025 | Propel, Fusion |
| Stryker Corporation | $379.94 | 2023-2024 | Scopis Ent |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Acclarent, INC | $84.02 | 2022-2024 | Trudi Nav Cable, Relieva Spinplus |
| Neurent Medical Limited | $43.24 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Aerin Medical INC. | $26.48 | 2025 | |
| Integra Lifesciences Corporation | $25.91 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Phadia US INC. | $15.01 | 2023 | Immunocap |
| Circassia INC. | $13.87 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gurston Nyquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.